CLEARWATER, Fla.–(BUSINESS WIRE)–Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2023 will be released before the market opens on Thursday, May 11th. Management will host a conference call at 8:00 … [Read more…]

BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–Zivo Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced a $1 million unsecured six-month loan from its Chairman, Chief Executive Officer, and President, John Payne. The loan carries 10% simple interest, may … [Read more…]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–$QNCX–Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that its Board of Directors (the “Board”) unanimously approved the adoption of a limited duration stockholder rights plan (the “Rights Plan”) and declared a dividend distribution of one preferred … [Read more…]

INDIANAPOLIS–(BUSINESS WIRE)–Elevance Health (NYSE: ELV) will release first quarter 2023 financial results on April 19, 2023, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its … [Read more…]

Jersey Mike’s Subs Raises $21 Million in March For Local Charities Nationwide MAPLEWOOD, N.J.–(BUSINESS WIRE)–#becauseofvalerie—The Valerie Fund joined forces with 125 Jersey Mike’s Subs in New Jersey for the 13th Annual March “Month of Giving” campaign to support local charities. During the month of March, customers made donations to The Valerie Fund at participating Jersey … [Read more…]

– Geared Toward Physicians, Medspoke is the only digital media platform that is voice-first – NEW YORK & HALIFAX, Nova Scotia–(BUSINESS WIRE)–#soundofmedicine–Watzan LLC today announced a breakthrough in audio technology with the introduction of Medspoke, currently the only commercialized digital media platform that is voice-first. Geared toward physicians, Medspoke allows 30-second “talks” from industry thought … [Read more…]

Grants support bioelectronic vagus nerve stimulation, five-year observational study of nighttime blood pressure MANHASSET, N.Y.–(BUSINESS WIRE)–The National Institutes of Health (NIH) has awarded Northwell Health’s Cohen Children’s Medical Center and The Feinstein Institutes for Medical Research, the homes of pediatric research at Northwell, two grants totaling $4.73 million to study nephrotic syndrome – a kidney … [Read more…]

New Age Veterinary Provider Bringing Personalized and Convenient Care to D.C. WASHINGTON–(BUSINESS WIRE)–#DC–Small Door Inc., a tech-enabled, membership-based veterinary care provider that operates under the brand Small Door Veterinary, today announced its expansion into Washington, D.C. with the planned April 5th opening of its state-of-the-art practice on 14th Street (2110 14th Street, NW). This opening … [Read more…]

Presentations to highlight the value of clinically relevant patient-derived xenograft (PDX) models for translational research and drug development SAN DIEGO–(BUSINESS WIRE)–#CertaintySavesLives–Certis Oncology Solutions (“Certis”), a precision oncology and translational science company focused on combining functional assays and artificial intelligence to advance personalized medicine, today announced that three abstracts have been accepted for presentation at the … [Read more…]

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, is pleased to announce the initiation of a Phase 1B study of its lead candidate, AST-004, as an extended infusion in healthy volunteers. This adaptive-design clinical study will be conducted over the next four to … [Read more…]